Life Sciences Chronicle
Ogan Gurel MD
Thinking about Life Sciences: Category Archive for Safety

FDA issues a "black box" warning for Avandia - A Balancing Act Between Safety and Choice

Posted by Ogan Gurel MD MPhil at 21 August 2007, 9:56 PM | Add Comment

The Deconstruction of Amgen

Posted by Ogan Gurel MD MPhil at 21 August 2007, 7:01 PM | Add Comment

Drug Safety & FDA Reform : An Audio (.mp3) Podcast

Posted by Ogan Gurel MD MPhil at 3 August 2007, 7:45 AM | Add Comment

Drug safety and FDA Reform: An Audio (.mp3) Podcast

Posted by Ogan Gurel MD MPhil at 2 August 2007, 6:34 AM | Add Comment

Accelerating Medical Technology Innovation, Drug/Device Safety and FDA Reform: InTimeTV broadcast

Posted by Ogan Gurel MD MPhil at 1 August 2007, 5:48 PM | Add Comment

FDA panel votes to retain Avandia on the market: DrugWonks celebrate; Prince Hal rails against Falstaff ...

Posted by Ogan Gurel MD MPhil at 31 July 2007, 7:50 PM | View Comments (8) | Add Comment | Trackbacks

InTimeTV interview. Live on Saturday, July 28th at 12noon (Central Time): Innovation, Life Sciences Accelerator, Drug Safety, FDA reform and other topics

Posted by Ogan Gurel MD MPhil at 27 July 2007, 7:40 PM | View Comments (2) | Add Comment

FDA Report on Avandia: Implications and a "critique" of the critique

Posted by Ogan Gurel MD MPhil at 26 July 2007, 5:58 PM | View Comments (1) | Add Comment

Boston Scientific, Medtronic settle some defibrillator suits; is the device safety storm over?

Posted by Ogan Gurel MD MPhil at 23 July 2007, 1:58 PM | View Comments (3) | Add Comment

Avandia, the Drug Safety Debate and How to Get a Nobel Prize

Posted by Ogan Gurel MD MPhil at 22 July 2007, 5:17 PM | Add Comment

Bleeding stents ... Is the drug-eluting stent era over?

Posted by Ogan Gurel MD MPhil at 19 July 2007, 3:56 PM | View Comments (4) | Add Comment

The Many Surprising Implications of Hip Resurfacing Implants

Posted by Ogan Gurel MD MPhil at 8 July 2007, 2:04 PM | View Comments (2) | Add Comment

FDA Reform Redux: On Business Models, Regulatory Reform and Safety

Posted by Ogan Gurel MD MPhil at 6 July 2007, 7:09 PM | View Comments (4) | Add Comment

Zangani Audio Webcast: Technology convergence, Personalized Medicine and Patient Safety

Posted by Ogan Gurel MD MPhil at 3 July 2007, 8:48 AM | Add Comment

FDA: Tortoise, Hare or Something Else

Posted by Ogan Gurel MD MPhil at 12 June 2007, 12:47 PM | Add Comment

Medical Design Excellence Awards Offer Decisive Glimpse Into Future of Health Care

Posted by Ogan Gurel MD MPhil at 20 February 2007, 5:24 PM | Add Comment

Subtle But Powerful, Publication Bias Goes Beyond Financial Incentives

Posted by Ogan Gurel MD MPhil at 9 January 2007, 9:22 PM | Add Comment

Drug-Eluting Stents, Part One: Triple Storm Catching Industry Attention

Posted by Ogan Gurel MD MPhil at 27 November 2006, 4:40 AM | Add Comment

Cosmetic Implantables: There’s More Beneath the Surface

Posted by Ogan Gurel MD MPhil at 31 October 2006, 3:19 AM | Add Comment

The Devil’s in the Details: A Closer Look at Merck’s Vioxx Trials

Posted by Ogan Gurel MD MPhil at 7 August 2006, 10:02 PM | Add Comment

Drug-Eluting Stent Market: $5 Billion Turning on a Dime

Posted by Ogan Gurel MD MPhil at 24 July 2006, 4:05 AM | Add Comment

The Future of Drug-Eluting Stents: A Big Issue or a Non-Issue?

Posted by Ogan Gurel MD MPhil at 26 June 2006, 7:14 PM | Add Comment

Drug /Device Safety Debate to Yield Big Changes, Grow More Controversial

Posted by Ogan Gurel MD MPhil at 1 May 2006, 3:36 AM | Add Comment
Copyright Aesis Research Group, LLC 2007. All rights reserved.